The aim of this study is to investigate if curcumin is detectable when subjects use curcumin supplements in daily life.
ID
Source
Brief title
Condition
- Malignant and unspecified neoplasms gastrointestinal NEC
- Vascular disorders NEC
Synonym
Research involving
Sponsors and support
Intervention
Outcome measures
Primary outcome
Plasma concentrations
Secondary outcome
Brand, type and dosage of the used foodsupplements. Information about the
medication patient use for regular care on the day of the visit.
Background summary
The interest in curcumin is growing and despite all the pre-clinical evidence
the effectiveness in clinical trials is very limited. The food supplements with
curcumin currently on the market as over the counter products are accompanied
with large advertisements and probably fallacious claims about the
bioavailability. The costs for these products are high and a price of 40-50
euros for one bottle is not uncommon. Despite all this patients are currently
using this supplement as additional care.
In this pilot research we want to investigate which products, formulations and
dosages patients use. We want to measure the plasma levels reached during
intake of these food supplements. We also want to have more inside in the
different food supplements patients use such as piperin and genistein.
Study objective
The aim of this study is to investigate if curcumin is detectable when subjects
use curcumin supplements in daily life.
Study design
This is a study into curcumin food supplements taken by subjects in daily life.
In which we aim to include 50 subjects.
The interventions in this study are:
• One questionnaire about the food supplement use by subjects
• Two blood samples will be collected, one before intake of their food
supplement with curcumin and one after intake of the food supplement.
Study burden and risks
In this study no product is involved as intervention or additional to their
daily routine. The only intervention that the including adult subject will
undergo is a two times sampling of their blood and completion of a
questionnaire.
Meibergdreef 9
Amsterdam 1105 AZ
NL
Meibergdreef 9
Amsterdam 1105 AZ
NL
Listed location countries
Age
Inclusion criteria
• Age >= 18 years
• Use of curcumin food supplement
• Able to give informed consent
Exclusion criteria
• Inability to give informed consent
• Inability to follow instructions of the investigator
Design
Recruitment
Followed up by the following (possibly more current) registration
No registrations found.
Other (possibly less up-to-date) registrations in this register
In other registers
Register | ID |
---|---|
CCMO | NL58755.018.16 |
OMON | NL-OMON25480 |